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Abstract 
Objective: To describe and analyze the availability and factors related to the presence of analgesics and 
non-steroidal anti-inflammatory drugs in the Brazilian public primary healthcare system. Material and 
Methods: This was a cross-sectional study that evaluated 17,903 health units that participated in the 
National Program for Primary Care Access and Quality Improvement (2013-2014). The dependent variable 
was defined as the presence of metamizole, ibuprofen, and acetaminophen in a sufficient amount. The 
independent variables included the type of primary health care unit, the presence of a medication disposal 
area, the number of physicians, nurses, and dental practitioners; and the number of primary care units with 
family and oral health teams. For statistical analysis, unadjusted and adjusted Odds Ratio (OR) (95% CI) 
were presented. Results: The three medicines were available in 62.4% of the units. Regarding Health 
Clinics, the Basic Health Units (OR= 1.31, CI95% 1.18-1.44), Polyclinic (OR= 2.00, 95% CI, 1.15 -3.48), and 
others (OR= 1.37; 95% CI 1.14-1.63) had higher chances of availability of all three drugs. The presence of a 
disposal area (OR = 1.64, 95% CI 1.51-1.77) and the number of physicians (OR= 1.04, 95% CI 1.00-1.08), 
nurses (OR= 1.08, 95% CI 1.03- 1.13), and dental practitioners (OR= 1.09, 95% CI 1.04-1.14) increased the 
availability odds of the analyzed drugs in the service. Conclusion: The structure of the healthcare units and 
the higher number of professionals were positively associated with the availability of these drugs. 
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Introduction 
Pain is a highly prevalent condition worldwide [1], as well as a major clinical, social, and economic 
issue that negatively impacts people’s quality of life [1-3]. In Brazil, it was estimated that 39% of adults suffer 
from chronic pain. Of these, 75% use painkillers, with analgesic and non-steroidal anti-inflammatory drugs 
(NSAIDs) being the most commonly consumed [4]. These drugs are a heterogeneous group of chemicals that 
share therapeutic activities, such as anti-inflammatory, analgesic, and antipyretic properties [5]. Regarding 
this matter, analgesics are among the most prescribed medicines and are considered to be “essential medicines” 
by the World Health Organization (WHO) [6-8]. 
Analgesics are the most consumed drugs in Brazil [9,10] and Primary Health Care (PHC) from the 
Brazilian National Health System (Sistema Único de Saúde – SUS, in Portuguese) should give comprehensive 
therapeutic care, including pharmaceutical [11]. The Brazilian Medicine Policy (PNM) [12] and the Brazilian 
Pharmaceutical Services Policy (PSP) [13] focus on access to safe, efficient, and high-quality medicines in the 
PHC. These policies have also adopted the National List of Essential Medicines (Relação Nacional de 
Medicamentos Essenciais – RENAME, in Portuguese), based on the WHO model list of essential medicines [8]. 
PHC has been evaluated in order to improve the quality and access of services to the population. The 
National Program for Primary Care Access and Quality Improvement (Programa Nacional de Melhoria do Acesso 
e da Qualidade da Atenção Básica – PMAQ-AB, in Portuguese) was a national strategy used by the Federal 
Government for this purpose. In the last decade, three cycles of national PHC evaluation have been developed 
by PMAQ-AB and the obtained data has been published. These surveys considered the characteristics of the 
healthcare services, including access to such essential medications as vitamins, antihypertensives, antidiabetics, 
analgesics and antipyretics, NSAIDS, antimicrobials, and psychotropics [14-16]. 
The lack of continuous access to essential medicines is a major public health issue, not only in Brazil 
but throughout the world. The WHO estimates that one-third of the world’s population does not have regular 
access to these medicines [17]. Physical structure, the good management of the healthcare services, and the 
presence of the pharmacist in the PHC units seems to be associated with higher availability rates [18-20]. 
PHC should provide essential medicines to the entire Brazilian population; however, out-of-pocket 
expenditure has been increasing over the years, compromising families’ incomes [21]. Considering Brazil’s 
huge territorial extension and the striking socioeconomic inequalities, few nationwide initiatives actually 
evaluate drug availability. In this light, this study aimed to describe and analyze the availability and factors 
related to the presence of analgesics and NSAIDS in the Brazilian public primary healthcare system. 
 
Material and Methods 
Study Design 
This is an analytical cross-sectional study that analyzed secondary data from 24,055 PHC units’ 
participants from the PMAQ-AB second cycle in Brazil (2013-2014). This is an open dataset that is available 
from the Brazilian Ministry of Health (MH) [22]. 
The PMAQ-AB was introduced by the MH in 2011. The program’s main goals were to improve 
access and the quality of healthcare services in PHC. It consisted of the mobilization of employees, managers, 
and users, aiming to bring about change in the work process and in the guidelines of PHC services according 
to the needs and satisfaction of the population. PMAQ-AB was an articulated strategy that consisted of the 
assessment and certification of PHC teams. Moreover, in accordance with the performance achieved by these 
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teams in the implementation and development of the standards and indicators evaluated by the program, 
financial incentives were transferred to the counties where the teams worked [14,15]. 
 
Data Collection 
Data on the characteristics of the PHC units were collected by a questionnaire that included, among 
other items, the presence of medicines. Both the development of the questionnaire used in the interviews and 
the data collection from health professionals were carried out with the collaboration of 46 Brazilian education 
and research institutions. The 989 interviewers were all senior healthcare professionals and were trained to 
conduct this survey nationwide. A 40-hour training included PHC content, survey methods, and PMAQ-AB 
questionnaires. All interviewers participated in a formal evaluation to assess their abilities. One supervisor was 
assigned to every three interviewers. The Brazilian MH developed an app for mobile devices, which presented 
the questions in an electronic format, thus allowing for data collection. Data were directly sent to an online 
database, and the MH was subsequently responsible for the analysis of consistency and the certification of the 
healthcare teams [15]. 
The interviewed population consisted of Brazilian health professionals who worked in PHC units that 
participated in the second cycle of PMAQ-AB. The interview with health professionals was voluntary. A total 
of 6,152 PHC units that did not dispose of medicines were excluded from this study. Therefore, this research 
considered 17,903 PHC units, where the drug disposal process was performed.  
The dependent variable in this study was defined as the presence of metamizole, ibuprofen, and 
acetaminophen in a sufficient amount, according to the perception of the interviewee, at PHC units. The 
dependent variable was evaluated qualitatively, that is, the interviewee's answer has been taken for granted. 
The MH claims that it would be impossible to define only one quantitative criterion to asses all the medicines 
and supplies.  
The independent variables included the type of PHC unit (health clinic, basic health unit, polyclinic, 
others); PHC units with a medication disposal area (yes/no); the number of physicians, nurses, and dental 
practitioners; and the number of PHC units with family and oral health teams. 
 
Data Analysis 
For statistical analysis, the SPSS Program, version 17.0, was used. Descriptive statistics and 
multivariate statistics were performed through binary logistical regression. First, each independent variable 
was tested one by one. Those with a p-value of less than 0.25 were included in the final model. Non-adjusted 
and adjusted Odds Ratio (95% Confidence Interval – 95% CI) were also estimated, using a Forward Stepwise 
method. Only variables with a p-value of less than 0.05 were maintained in the final model. The linearity of the 
logit was checked for continuous variables. Residuals were evaluated by Cook´s distance and multicollinearity 
were evaluated by the Variance Inflation Factor (VIF). Hosmer & Lemeshow’s goodness of fit test was also 
performed. 
 
Ethical Aspects 
The Research Ethics Committee of the Federal University of Minas Gerais approved this research, 
logged under Protocol No. 02396512.8.0000.5149. 
 
Results 
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The overall availability in the PHC units of the three medicines in sufficient amounts was 62.4%. The 
variable descriptions are presented in Table 1. 
 
Table 1. Description of the analyzed variables on the external evaluation from the 
second’s PMAQ-AB cycle. 
Variables N % 
Type of PHC Unit   
Health Clinic 1,756 9.8 
Basic Health Unit 15,334 85.6 
Policlinic 68 0.4 
Other 745 4.2 
PHC units with a Medication Disposal Area   
Yes 14,950 83.5 
No 2,953 16.5 
Metamizole in Sufficient Amount   
Yes 14,392 80.4 
No 3,511 19.6 
Ibuprofen in Sufficient Amount   
Yes 13,397 74.8 
No 4,506 2.2 
Acetaminophen in Sufficient Amount   
Yes 15,574 87.0 
No 2,329 13.0 
Metamizole, Ibuprofen and Acetaminophen in Sufficient Amount   
Yes 11,171 62.4 
No 6,732 37.6 
Number of Healthcare Professionals Median Range 
Physicians 1 0-21 
Nurses 1 0-18 
Dental Practitioners 1 0-19 
Number of PHC Units with Family and Oral Health Teams 1 0-15 
PHC: Primary Health Care. 
 
The final model identified that, when compared to health clinics (Posto de Saúde, in Portuguese), basic 
health units (OR = 1.31, CI95% 1.18-1.44), polyclinics (OR = 2.00, 95% CI, 1.15-3.48), and other PHC units 
(OR = 1.37; 95% CI 1.14-1.63) showed an increased chance of presenting the three drugs. PHC units with a 
medication disposal area (OR = 1.64, 95% CI 1.51-1.77) and the number of physicians (OR = 1.04, 95% CI 
1.00-1.08), nurses (OR = 1.08, 95% CI 1.03-1.13), and dental practitioners (OR = 1.09, 95% CI 1.04-1.14) 
increased the odds for availability of the drugs in the healthcare service (Table 2). 
 
Table 2. Associated factors related to the presence of analgesics and NSAIDs in a sufficient amount. 
Variables Unadjusted OR 
 (CI95%) 
 
p-value 
Adjusted OR 
(CI95%) 
 
p-value 
Type of PHC Unit     
Health Clinic 1 - 1 - 
Basic Health Unit 1.37 (1.24–1.51) <0.001 1.31 (1.18–1.44) <0.001 
Policlinic 2.23 (1.29–3.85) 0.004 2.00 (1.15–3.48) 0.014 
Other 1.46 (1.22–1.74) <0.001 1.37 (1.14–1.63) <0.001 
PHC Units with a Medication Disposal Area 
No 1 - 1 - 
Yes 1.76 (1.62–1.90) <0.001 1.64 (1.51–1.77) <0.001 
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Number of Healthcare Professionals 
Physicians 1.14 (1.12–1.17) <0.001 1.04 (1.00–1.08) 0.032 
Nurses 1.19 (1.16–1.23) <0.001 1.08 (1.03–1.13) 0.003 
Dental Practitioners 1.21 (1.17–1.27) <0.001 1.09 (1.04–1.14) <0.001 
Number of PHC Units with Family 
and Oral Health Teams 
1.11 (1.07–1.15) <0.001 - - 
PHC: Primary Health Care. 
 
None of the continuous variables violated the assumption of the linearity of logit. Cook´s Distance was 
lower than 1 (ranging from 0.0001 to 0.1174), indicating no influential cases. VIF values ranged from 1.019 to 
2.669, indicating no issue in multicollinearity. The multiple logistical regression model was considered 
adequate (p=0.573; Hosmer-Lemeshow’s test). 
 
Discussion 
In this study, the number of PHC units where the analyzed medicines were available in sufficient 
amounts was 62.4%. The type of PHC unit, the presence of a medication disposal area, and the number of 
physicians, nurses, and dental practitioners were positively associated with the outcome. 
The adequate physical structure of the PHC units was directly associated with the higher availability 
of painkillers. Some published studies indicate that more well-structured healthcare units have better 
conditions to stock the medicines properly. Moreover, temperature control by an air-conditioning system in 
the storage room, the presence of a refrigerator in which to lay thermolabile medications, and the presence of a 
computerized system were linked to higher availability rates [18-20]. According to current Brazilian 
legislation, a health clinic is a unit that provides health assistance to a specific population by a mid-level 
professional, with or without the intermittent physical presence of a physician [23]. This might explain the 
lowest availability of metamizole, acetaminophen, and ibuprofen found in the health clinics, since the physician 
might not always be in the unit and mid-level professionals, according to Brazilian legislation, are not allowed 
to prescribe medications. Regarding the polyclinics, these PHC units offer outpatient care in many specialties, 
including non-medical care [23]; hence, the higher density of healthcare professionals is believed to be found 
in these units. Therefore, the polyclinics might be a planned facility to support the demand and host the 
necessary equipment. This corroborates the findings in this survey that physical structure and human 
resources are associated with higher odds of the PHC unit having the three analyzed medicines. 
Healthcare professionals who are able to prescribe medications include physicians, nurses, and dental 
practitioners. It was estimated that more than 60% of all doctor´s or dentist´s appointments result in 
prescriptions [24]. As analgesics and NSAIDs are widely prescribed and consumed in Brazil [9,10], it is 
expected that the PHC units that have a higher number of healthcare professionals will consequently have 
higher availability rates.  
The main goals of the PNM and the PSP are to guide the acquisition of medicine and their 
distribution, ensuring the rational use of drugs and promoting the population’s access to essential medicine 
[12,13]. Despite these policies, this study noticed that 37.6% of the PHC facilities did not have the analyzed 
medicines in sufficient amounts, even though metamizole, ibuprofen, and acetaminophen are part of the 
RENAME and are being manufactured by Brazil’s Official Pharmaceutical Laboratories [25]. 
Metamizole, acetaminophen, and ibuprofen occupied the 7th, 8th, and 12th positions, respectively, in a 
ranking of the medicines most used by outpatients in PHC in the public sector [10]. This could be explained 
by the broad spectrum of conditions treated by these medicines, including rheumatoid arthritis, osteoarthritis, 
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musculoskeletal pain, pre-emptive and post-operative surgeries, dental treatments, among others [26-28]. 
Insufficient access to these medicines means that a large percentage of the Brazilian population experience the 
burdens of acute and chronic pain, such as delayed wound healing, increased number of secondary doctor´s 
appointments, and additional treatment costs. Pain is known to be a noxious experience and can have a 
negative effect on almost every other aspect of life, including one’s daily routine, mood, and decline in work 
productivity [6]. 
Previous research evaluated adults’ access to medicines to manage acute medical conditions in the 
Brazilian Northeast and South. It was found that in both geographic regions the greater access to analgesic 
and NSAIDs prescribed in the SUS was paid out-of-pocket [21]. According to the WHO, drug-related 
expenses is the largest family expenditure item after food supply [29]. This highlights the economic burden of 
the lack of access to essential medicines, especially between people in disadvantaged or low-income regions. 
In Brazil, the pharmaceutical assistance of the entire public health system is decentralized. Poor 
planning, lackluster management, and the lack of financial resources from funding sources are associated with 
low medicine availability rates [19]. Previous research proposes interventions to cope with this low 
availability, such as social control, the existence of a Permanent Bidding Committee to buy medicines, and the 
regular participation of the professionals responsible for the disposal of medicines in the Municipal health 
council meetings [20]. 
The disposal of basic components of the medicines in primary care are the responsibility of the 
municipal government. RENAME is a referential instrument to guide the selection of drugs, but the Brazilian 
counties’ managers have the autonomy to create a list of essential medicines according to the population´s 
epidemiological demand [12]. The limitations of this study were that the low availability of the medicines 
analyzed could have been compensated by the offer of other products with the same indication defined by the 
municipal level. The huge number of counties in Brazil also made it impossible to verify those lists, which is a 
limitation also reported in prior studies [18]. Another limitation is that the assessment process of availability 
occurred within a single measurement, which does not reflect the dynamic reality of the input and output 
within the medicine disposal process. This directs attention to the need for further research in the availability 
of medicines in Brazil. 
 
Conclusion 
Regarding the PHC units analyzed in this survey, more than a third did not have metamizole, 
ibuprofen, and acetaminophen in sufficient amounts. The physical structure, an area for medicine disposal, and 
the number of health professionals were directly associated with a higher probability of the availability of these 
drugs. 
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